562 related articles for article (PubMed ID: 18824904)
1. The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury.
Durão MS; Monte JC; Batista MC; Oliveira M; Iizuka IJ; Santos BF; Pereira VG; Cendoroglo M; Santos OF
Crit Care Med; 2008 Nov; 36(11):3024-9. PubMed ID: 18824904
[TBL] [Abstract][Full Text] [Related]
2. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition.
Bihorac A; Ross EA
Am J Kidney Dis; 2005 Nov; 46(5):908-18. PubMed ID: 16253732
[TBL] [Abstract][Full Text] [Related]
3. Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge.
Gabutti L; Marone C; Colucci G; Duchini F; Schönholzer C
Intensive Care Med; 2002 Oct; 28(10):1419-25. PubMed ID: 12373466
[TBL] [Abstract][Full Text] [Related]
4. Effect of filtration volume of continuous venovenous hemofiltration in the treatment of patients with acute renal failure in intensive care units.
Brause M; Neumann A; Schumacher T; Grabensee B; Heering P
Crit Care Med; 2003 Mar; 31(3):841-6. PubMed ID: 12626994
[TBL] [Abstract][Full Text] [Related]
5. Continuous venovenous hemodiafiltration versus hemodialysis as renal replacement therapy in patients with acute renal failure in the intensive care unit.
Chang JW; Yang WS; Seo JW; Lee JS; Lee SK; Park SK
Scand J Urol Nephrol; 2004; 38(5):417-21. PubMed ID: 15764254
[TBL] [Abstract][Full Text] [Related]
6. Acute kidney injury criteria predict outcomes of critically ill patients.
Barrantes F; Tian J; Vazquez R; Amoateng-Adjepong Y; Manthous CA
Crit Care Med; 2008 May; 36(5):1397-403. PubMed ID: 18434915
[TBL] [Abstract][Full Text] [Related]
7. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status.
Morgera S; Schneider M; Slowinski T; Vargas-Hein O; Zuckermann-Becker H; Peters H; Kindgen-Milles D; Neumayer HH
Crit Care Med; 2009 Jun; 37(6):2018-24. PubMed ID: 19384210
[TBL] [Abstract][Full Text] [Related]
8. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
Chadha V; Garg U; Warady BA; Alon US
Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
[TBL] [Abstract][Full Text] [Related]
9. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
[TBL] [Abstract][Full Text] [Related]
10. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
Burry LD; Tung DD; Hallett D; Bailie T; Carvalhana V; Lee D; Ramganesh S; Richardson R; Mehta S; Lapinsky SE
Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
[TBL] [Abstract][Full Text] [Related]
11. Regional citrate anticoagulation for intermittent predilution online hemofiltration.
Gubensek J; Buturović-Ponikvar J; Skofic N; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):306-9. PubMed ID: 19695064
[TBL] [Abstract][Full Text] [Related]
12. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients.
Thoenen M; Schmid ER; Binswanger U; Schuepbach R; Aerne D; Schmidlin D
Wien Klin Wochenschr; 2002 Feb; 114(3):108-14. PubMed ID: 12060967
[TBL] [Abstract][Full Text] [Related]
13. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
[TBL] [Abstract][Full Text] [Related]
14. Comparison of sustained hemodiafiltration with continuous venovenous hemodiafiltration for the treatment of critically ill patients with acute kidney injury.
Abe M; Okada K; Suzuki M; Nagura C; Ishihara Y; Fujii Y; Ikeda K; Kaizu K; Matsumoto K
Artif Organs; 2010 Apr; 34(4):331-8. PubMed ID: 20420616
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of citrate anti-coagulation continuous renal replacement therapies in post-cardiac surgery patients with liver dysfunction.
De Vico P; Messino V; Tartaglione A; Beccaris C; Buonomo C; Talarico D; Prati P; Sabato AF; Colella DF
Ther Apher Dial; 2015 Jun; 19(3):272-8. PubMed ID: 25656632
[TBL] [Abstract][Full Text] [Related]
16. Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration.
Hetzel GR; Taskaya G; Sucker C; Hennersdorf M; Grabensee B; Schmitz M
Am J Kidney Dis; 2006 Nov; 48(5):806-11. PubMed ID: 17060000
[TBL] [Abstract][Full Text] [Related]
17. Continuous renal replacement therapy improves survival in severely burned military casualties with acute kidney injury.
Chung KK; Juncos LA; Wolf SE; Mann EE; Renz EM; White CE; Barillo DJ; Clark RA; Jones JA; Edgecombe HP; Park MS; Albrecht MC; Cancio LC; Wade CE; Holcomb JB
J Trauma; 2008 Feb; 64(2 Suppl):S179-85; discussion S185-7. PubMed ID: 18376163
[TBL] [Abstract][Full Text] [Related]
18. Comparison of continuous and intermittent renal replacement therapy for acute renal failure.
Uehlinger DE; Jakob SM; Ferrari P; Eichelberger M; Huynh-Do U; Marti HP; Mohaupt MG; Vogt B; Rothen HU; Regli B; Takala J; Frey FJ
Nephrol Dial Transplant; 2005 Aug; 20(8):1630-7. PubMed ID: 15886217
[TBL] [Abstract][Full Text] [Related]
19. Comparison of citrate anticoagulation during plasma exchange with different replacement solutions.
Antonic M; Gubensek J; Buturović-Ponikvar J; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):322-6. PubMed ID: 19695068
[TBL] [Abstract][Full Text] [Related]
20. Continuous veno-venous hemodiafiltration in children after cardiac surgery.
Jander A; Tkaczyk M; Pagowska-Klimek I; Pietrzykowski W; Moll J; Krajewski W; Nowicki M
Eur J Cardiothorac Surg; 2007 Jun; 31(6):1022-8. PubMed ID: 17403606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
